anti-VZV MAb (PDL)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-VZV MAb (PDL)
Drug Alias Nameantivaricella MAb (Sandoz)anti-VZV MAb (Protein Design Labs)antivaricella MAb (PDL)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSandoz AgPdl Biopharma Inc
Active IndicationsN/A
Inactive IndicationsVaricella Zoster Virus Infection

Other Information

ATC CodeN/A
Related LinksN/A